Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Celltrion Merger Announcement: Details, Questionable Aspects, & Trading Dynamics

Korea Stock Market Monthly Recap #52 (September 2020)

Hyundai Mobis - Restarts Its Big Share Buyback Program in 4Q 2020

A Potential Merger of Celltrion, Celltrion Healthcare, & Celltrion Pharma?

Celltrion Healthcare: Block Deal Sale by One Equity Partners (Time to Turn Bearish)

Celltrion Pair Trade: Healthcare Being Pushed Out a Little Too Extreme

Event-Driven

<div class="content-highlight">
After the market close today, there was a major announcement in the healthcare sector in Korea. <a href="https://www.smartkarma.com/entities/celltrion-inc" target="_blank" data-smartkarma-citation="entities:991:1" rel="noopener">Celltrion Inc (068270 KS)</a>, <a href="https://www.smartkarma.com/entities/celltrion-healthcare" target="_blank" data-smartkarma-citation="entities:23641:1" rel="noopener">Celltrion Healthcare (091990 KS)</a>, and <a href="https://www.smartkarma.com/entities/celltrion-pharm-inc" target="_blank" data-smartkarma-citation="entities:992:1" rel="noopener">Celltrion Pharm (068760 KS)</a> will be MERGED into one company. Plus, a NEWCO called Celltrion Healthcare Holdings is established.
Overall, we believe that this will be positive for the three Celltrion Group companies over a 6-12 months view. However, the overall impact is not likely to be overly significant since early this year, the Celltrion Group Chairman Seo Jung-Jin already hinted that there could be a merger among these three companies.
One of the main reasons why the Celltrion Group stocks have done well so far this year has been due to the expectation of the formal merger announcement. As a result, there could be some investors that may actually try to sell the three Celltrion Group related stocks on this news in the near-term. 
</div>


After the market close today, there was a major announcement in the healthcare sector in Korea. Celltrion Inc (068270 KS), Celltrion Healthcare (091990 KS), and Celltrion Pharm (068760 KS) will be MERGED into one company. Plus, a NEWCO called Celltrion Healthcare Holdings is established.
Overall, we believe that this will be positive for the three Celltrion Group companies over a 6-12 months view. However, the overall impact is not likely to be overly significant since early this year, the Celltrion Group Chairman Seo Jung-Jin already hinted that there could be a merger among these three companies.
One of the main reasons why the Celltrion Group stocks have done well so far this year has been due to the expectation of the formal merger announcement. As a result, there could be some investors that may actually try to sell the three Celltrion Group related stocks on this news in the near-term. 


セルトリオングループ3社の合併とセルトリオン・ヘルスケア・ホールディングスの設立